drugset / Trial / NCT07190482

Treatment of Tinnitus With Olanzapine

NCT07190482

Phase 1 Completed 50 enrolled University of Sao Paulo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research aims to evaluate the effects of the drug olanzapine on the discomfort caused by tinnitus according to each patient's personality traits. Olanzapine is a drug used as an antipsychotic whose mechanism of action makes it potentially useful for the treatment of tinnitus.

Timeline

Start
2023-10-01
Primary completion
2024-12-20
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olanzapine Small molecule 5 mg Oral

Indications